Eric Lefebvre
CIK 1614741 · Chief Medical Officer · last filed 2025-01-27
Eric Lefebvre is a Chief Medical Officer who has filed 28 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for PLRX, was dated Jan 27, 2025. Across all open-market trades the lifetime net is −$5.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $271.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$271.5K
3
28
-$5.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PLRX | Chief Medical Officer | 240,224 | $1.13 | $271.5K | -$5.13M | 20 | 2025-01-27 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 4 | 2024-03-22 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Chief Medical Officer | — | — | — | $0 | 3 | 2016-01-14 |
Recent Filings
28 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-27 | PLRX | Grant (A) | +45,650 | $0 | EDGAR |
| 2025-01-22 | PLRX | Sell (S) | −18,478 | -$207.0K | EDGAR |
| 2024-07-12 | PLRX | Sell (S) | −12,319 | -$142.4K | EDGAR |
| 2024-07-11 | PLRX | Grant (A) | +24,063 | $0 | EDGAR |
| 2024-03-22 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Disp (D) | — | $0 | EDGAR |
| 2024-01-26 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-24 | PLRX | Grant (A) | +42,900 | $0 | EDGAR |
| 2024-01-19 | PLRX | Sell (S) | −10,295 | -$177.4K | EDGAR |
| 2023-07-19 | PLRX | Sell (S) | −22,321 | -$402.0K | EDGAR |
| 2023-07-18 | PLRX | Grant (A) | +43,750 | $0 | EDGAR |